China’s 2026 Inbound Medical Aesthetics Policy Boost: Compliance Advantages and Practical Guidance for Overseas Patients Seeking Cosmetic Surgery in China
2026-08-12
In March 2026, China’s Ministry of Commerce, Ministry of Culture and Tourism, National Immigration Administration, and six other government departments jointly issued the Policy Measures on Promoting Travel Service Exports and Expanding Inbound Consumption. The measures clearly identify cosmetic surgery, premium health checkups, and rehabilitation care as key categories for international medical tourism, with support policies covering visas, pharmaceuticals and medical devices, and service infrastructure. As a result, medical aesthetics travel to China is becoming significantly more compliant, accessible, and convenient.
I. Key Policy Benefits for Inbound Medical Aesthetics in China in 2026 The newly introduced policies provide support for overseas patients seeking medical aesthetics in China across three key areas: entry procedures, pharmaceuticals and medical devices, and service infrastructure. The main benefits include the following: 1. Major Improvements in Visa Convenience In addition to the 30-day visa-free policy covering 54 countries and the S2 medical visa allowing stays of up to 180 days, patients participating in key international medical cooperation programs may also access a port-of-entry visa-free fast-track channel through invitations from nationally designated medical institutions. With an official invitation letter from the institution, eligible patients can enter directly through key ports such as Beijing, Shanghai, Guangzhou, and Hainan without applying for a visa in advance. Visa extension procedures have also been further simplified, making it easier for patients who need to stay longer for postoperative recovery to complete the process within China. 2. Exclusive Special Policie...